GABA analogs containing phenyl (phenibut) or para-chlorophenyl (baclofen) substituents demonstrated nootropic activity in a dose of 20 mg/kg: they improved passive avoidance conditioning, decelerated its natural extinction, and exerted antiamnestic effect on the models of amnesia provoked by scopolamine or electroshock. Tolyl-containing GABA analog (tolibut, 20 mg/kg) exhibited antiamnestic activity only on the model of electroshock-induced amnesia. Baclofen and, to a lesser extent, tolibut alleviated seizures provoked by electroshock, i.e. both agents exerted anticonvulsant effect. All examined GABA aryl derivatives demonstrated neuroprotective properties on the maximum electroshock model: they shortened the duration of coma and shortened the period of spontaneous motor activity recovery. In addition, these agents decreased the severity of passive avoidance amnesia and behavioral deficit in the open field test in rats exposed to electroshock. The greatest neuroprotective properties were exhibited by phenyl-containing GABA analog phenibut.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
L. E. Borodkina, V. V. Bagmetova, and I. N. Tyurenkov, Vopr. Biol. Med. Farmakol. Khim., 10, No. 8, 14–20 (2012).
L. I. Bugaeva, A. A. Spasov, V. E. Verovskii, Eksp. Klin. Farmakol., 67, No. 3, 61–65 (2004).
T. A. Voronina, R. U. Ostrovskaya, and T. L. Garibova, Textbook on Preclinical Testing of Medicinal Remedies [in Russian], Ed. A. N. Mironov, Vol. 1, Moscow (2012), pp. 276–296.
T. A. Voronina and S. B. Seredenin, Eksp. Klin. Farmakol., 70, No. 4, 44–58 (2007).
R. S. Mirzoyan, Eksp. Klin. Farmakol., 66, No. 2, 53–56 (2003).
M. V. Nesterkina, E. A. Alekseeva, and I. A. Kravchenko, Khim. Farmakol. Zh., 48, No. 2, 13–16 (2014).
V. N. Perfi lova, L. B. Ivanova, V. I. Karamysheva, and D. D. Borodin, Eksp. Klin. Farmakol., 75, No. 3, 18–20 (2012).
V. N. Perfi lova, O. V. Ostrovskii, V. E. Verovskii, et al., Bull. Exp. Biol. Med., 143, No. 3, 341–343 (2007).
I. A. Tregubova, V. A. Kosolapov, A. A. Spasov, and V. A. Anisimova, Bull. Exp. Biol. Med., 156, No. 6, 793–795 (2014).
I. N. Tyurenkov, V. V. Bagmetova, L. E. Borodkina, et al., Eksp. Klin. Farmakol., 75, No. 6, 8–13 (2012).
I. N. Tyurenkov, L. E. Borodkina, and V. V. Bagmetova, Bull. Exp. Biol. Med., 153, No. 5, 710–713 (2012).
I. N. Tyurenkov, L. E. Borodkina, and A. V. Voronkov, Vestn. Volgograd. Gos. Med. Univer., No. 11, 24–26 (2004).
V. V. Yasnetsov, Vestn. Volgograd. Gos. Med. Univer., No. 4, 46–48 (2007).
С. К. Thomas, С. К. Häger-Ross, and C. S. Klein, Brain, 133, Pt 1, 117–125 (2010).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 160, No. 10, pp. 468–473, October 2015
Rights and permissions
About this article
Cite this article
Tyurenkov, I.N., Borodkina, L.E., Bagmetova, V.V. et al. Comparison of Nootropic and Neuroprotective Features of Aryl-Substituted Analogs of Gamma-Aminobutyric Acid. Bull Exp Biol Med 160, 465–469 (2016). https://doi.org/10.1007/s10517-016-3198-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-016-3198-4